1. Hedley, A. A. et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002.J. Am. Med. Assoc.291, 2847–2850 (2004).

   Article CAS  Google Scholar 

2. World Health Organization Consultation on Obesity 1–253 (World Health Organization, Geneva, 2000).

3. Wild, S., Roglic, G., Green, A., Sicree, R. & King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diabetes Care27, 1047–1053 (2004).

   PubMed  Google Scholar 

4. Reaven, G. M. Role of insulin resistance in human disease.Diabetes37, 1595–1607 1988).

   CAS PubMed  Google Scholar 

5. Perley, M. & Kipnis, D. M. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.Diabetes15, 867–874 (1966).

   CAS PubMed  Google Scholar 

6. Polonsky, K. S., Given, B. D. & Van Cauter, E. Twenty-four-hour profiles and patterns of insulin secretion in normal and obese subjects.J. Clin. Invest.81, 442–448 (1988).

   CAS PubMed PubMed Central  Google Scholar 

7. Kahn, S. E. et al. Quantification of the relationship between insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function.Diabetes42, 1663–1672 (1993).

   CAS PubMed  Google Scholar 

8. Kahn, S. E. The importance of β-cell failure in the development and progression of type 2 diabetes.J. Clin. Endocrinol. Metab.86, 4047–4058 (2001).

   CAS PubMed  Google Scholar 

9. Moran, A. et al. Insulin resistance during puberty: results from clamp studies in 357 children.Diabetes48, 2039–2044 (1999).

   CAS PubMed  Google Scholar 

10. Buchanan, T. A., Metzger, B. E., Freinkel, N. & Bergman, R. N. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes.Am. J. Obstet. Gynecol.162, 1008–1014 (1990).

    CAS PubMed  Google Scholar 

11. DeFronzo, R. A. Glucose intolerance of aging. Evidence for tissue insensitivity to insulin.Diabetes28, 1095–1101 (1979).

    CAS PubMed  Google Scholar 

12. Goodyear, L. J. & Kahn, B. B. Exercise, glucose transport, and insulin sensitivity.Annu. Rev. Med.49, 235–261 (1998).

    CAS PubMed  Google Scholar 

13. Chen, M., Bergman, R. N. & Porte, D. Insulin resistance and β-cell dysfunction in aging: the importance of dietary carbohydrate.J. Clin. Endocrinol. Metab.67, 951–957 (1988).

    CAS PubMed  Google Scholar 

14. Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes.J. Clin. Invest.115, 1111–1119 (2005).

    CAS PubMed PubMed Central  Google Scholar 

15. Scherer, P. E. Adipose tissue: from lipid storage compartment to endocrine organ.Diabetes55, 1537–1545 (2006).

    CAS PubMed  Google Scholar 

16. Shoelson, S. E., Lee, J. & Goldfine, A. B. Inflammation and insulin resistance.J. Clin. Invest.116, 1793–1801 (2006).

    CAS PubMed PubMed Central  Google Scholar 

17. Yang, Q. et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.Nature436, 356–362 (2005).

    ADS CAS PubMed  Google Scholar 

18. Kadowaki, T. et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.J. Clin. Invest.116, 1784–1792 (2006).

    CAS PubMed PubMed Central  Google Scholar 

19. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. & Bahouth, S. W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.Endocrinology145, 2273–2282 (2004).

    CAS PubMed  Google Scholar 

20. Mooney, R. A. et al. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance.J. Biol. Chem.276, 25889–25893 (2001).

    CAS PubMed  Google Scholar 

21. Perreault, M. & Marette, A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle.Nature Med.7, 1138–1143 (2001).

    CAS PubMed  Google Scholar 

22. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue.J. Clin. Invest.112, 1796–1808 (2003).

    CAS PubMed PubMed Central  Google Scholar 

23. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.J. Clin. Invest.112, 1821–1830 (2003).

    CAS PubMed PubMed Central  Google Scholar 

24. Reaven, G. M., Hollenbeck, C., Jeng, C. Y., Wu, M. S. & Chen, Y. D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.Diabetes37, 1020–1024 (1988).

    CAS PubMed  Google Scholar 

25. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.Diabetes46, 3–10 (1997).

    CAS PubMed  Google Scholar 

26. Roden, M. et al. Mechanism of free fatty acid-induced insulin resistance in humans.J. Clin. Invest.97, 2859–2865 (1996).

    CAS PubMed PubMed Central  Google Scholar 

27. Santomauro, A. T. et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.Diabetes48, 1836–1841 (1999).

    CAS PubMed  Google Scholar 

28. Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.Lanceti, 785–789 (1963).

    Google Scholar 

29. Shulman, G. I. Cellular mechanisms of insulin resistance.J. Clin. Invest.106, 171–176 (2000).

    CAS PubMed PubMed Central  Google Scholar 

30. Carey, D. G., Jenkins, A. B., Campbell, L. V., Freund, J. & Chisholm, D. J. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.Diabetes45, 633–638 (1996).

    CAS PubMed  Google Scholar 

31. Cnop, M. et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments.Diabetes51, 1005–1015 (2002).

    CAS PubMed  Google Scholar 

32. Kahn, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes.Diabetologia46, 3–19 (2003).

    CAS PubMed  Google Scholar 

33. Fujimoto, W. Y. et al. Preventing diabetes — applying pathophysiological and epidemiological evidence.Br. J. Nutr.84 (Suppl. 2), S173–S176 (2000).

    CAS PubMed  Google Scholar 

34. Maeda, K. et al. Analysis of an expression profile of genes in the human adipose tissue.Gene190, 227–235 (1997).

    CAS PubMed  Google Scholar 

35. Motoshima, H. et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone.J. Clin. Endocrinol. Metab.87, 5662–5667 (2002).

    CAS PubMed  Google Scholar 

36. Reynisdottir, S., Dauzats, M., Thorne, A. & Langin, D. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue.J. Clin. Endocrinol. Metab.82, 4162–4166 (1997).

    CAS PubMed  Google Scholar 

37. Montague, C. T. & O'Rahilly, S. The perils of portliness: causes and consequences of visceral adiposity.Diabetes49, 883–888 (2000).

    CAS PubMed  Google Scholar 

38. Kim, S. P., Ellmerer, M., Van Citters, G. W. & Bergman, R. N. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog.Diabetes52, 2453–2460 (2003).

    CAS PubMed  Google Scholar 

39. Kloppel, G., Lohr, M., Habich, K., Oberholzer, M. & Heitz, P. U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited.Surv. Synth. Pathol. Res.4, 110–125 (1985).

    CAS PubMed  Google Scholar 

40. Butler, A. E. et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes.Diabetes52, 102–110 (2003).

    CAS PubMed  Google Scholar 

41. Chen, C., Hosokawa, H., Bumbalo, L. M. & Leahy, J. L. Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in β-cells.J. Clin. Invest.94, 399–404 (1994).

    CAS PubMed PubMed Central  Google Scholar 

42. Liu, Y. Q., Jetton, T. L. & Leahy, J. L. β-cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats.J. Biol. Chem.277, 39163–39168 (2002).

    CAS PubMed  Google Scholar 

43. Kahn, S. E. et al. Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance.Diabetes38, 562–568 (1989).

    CAS PubMed  Google Scholar 

44. Kahn, S. E. et al. Effect of exercise on insulin action, glucose tolerance and insulin secretion in aging.Am. J. Physiol.258, E937–E943 (1990).

    CAS PubMed  Google Scholar 

45. Dobbins, R. L. et al. A fatty acid-dependent step is critically important for both glucose — and non-glucose — stimulated insulin secretion.J. Clin. Invest.101, 2370–2376 (1998).

    CAS PubMed PubMed Central  Google Scholar 

46. Prentki, M., Joly, E., El-Assaad, W. & Roduit, R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes.Diabetes51 (Suppl. 3), S405–S413 (2002).

    CAS PubMed  Google Scholar 

47. Bergman, R. N. et al. Why visceral fat is bad: mechanisms of the metabolic syndrome.Obesity14 (Suppl. 1), 16S–19S (2006).

    CAS PubMed  Google Scholar 

48. Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40.Nature422, 173–176 (2003).

    ADS CAS PubMed  Google Scholar 

49. Drucker, D. J. The biology of incretin hormones.Cell Metab.3, 153–165 (2006).

    CAS PubMed  Google Scholar 

50. Verdich, C. et al. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety — effect of obesity and weight reduction.Int. J. Obes. Relat. Metab. Disord.25, 1206–1214 (2001).

    CAS PubMed  Google Scholar 

51. Berthoud, H. R. & Jeanrenaud, B. Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats.Endocrinology105, 146–151 (1979).

    CAS PubMed  Google Scholar 

52. Ahren, B., Taborsky, G. J. & Porte, D. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion.Diabetologia29, 827–836 (1986).

    CAS PubMed  Google Scholar 

53. Hull, R. L. et al. Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.Diabetologia48, 1350–1358 (2005).

    CAS PubMed  Google Scholar 

54. Sorenson, R. L. & Brelje, T. C. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones.Horm. Metab. Res.29, 301–307 (1997).

    CAS PubMed  Google Scholar 

55. Bonner-Weir, S., Deery, D., Leahy, J. L. & Weir, G. C. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion.Diabetes38, 49–53 (1989).

    CAS PubMed  Google Scholar 

56. Steil, G. M. et al. Adaptation of β-cell mass to substrate oversupply: enhanced function with normal gene expression.Am. J. Physiol. Endocrinol. Metab.280, E788–E796 (2001).

    CAS PubMed  Google Scholar 

57. Rhodes, C. J. Type 2 diabetes — a matter of β-cell life and death?Science307, 380–384 (2005).

    ADS CAS PubMed  Google Scholar 

58. Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M. & Permutt, M. A. Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia.J. Clin. Invest.108, 1631–1638 (2001).

    CAS PubMed PubMed Central  Google Scholar 

59. Hennige, A. M. et al. Upregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes.J. Clin. Invest.112, 1521–1532 (2003).

    CAS PubMed PubMed Central  Google Scholar 

60. Kiba, T. et al. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation.Gastroenterology110, 885–893 (1996).

    CAS PubMed  Google Scholar 

61. Røder, M. E., Porte, D. & Kahn, S. E. Disproportionately elevated proinsulin levels reflect the degree of impaired B-cell secretory capacity in patients with non-insulin dependent diabetes mellitus.J. Clin. Endocrinol. Metab.83, 604–608 (1998).

    PubMed  Google Scholar 

62. Garvey, W. T., Olefsky, J. M., Griffen, J., Hamman, R. F. & Kolterman, O. G. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.Diabetes34, 222–234 (1985).

    CAS PubMed  Google Scholar 

63. Kahn, S. E., Bergman, R. N., Schwartz, M. W., Taborsky, G. J. & Porte, D. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans.Am. J. Physiol.262, E518–E523 (1992).

    CAS PubMed  Google Scholar 

64. Sako, Y. & Grill, V. E. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.Endocrinology127, 1580–1589 (1990).

    CAS PubMed  Google Scholar 

65. Zhou, Y. P. & Grill, V. E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.J. Clin. Invest.93, 870–876 (1994).

    CAS PubMed PubMed Central  Google Scholar 

66. Carpentier, A. et al. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.Am. J. Physiol.276, E1055–E1066 (1999).

    CAS PubMed  Google Scholar 

67. Utzschneider, K. M. et al. Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses.Diabetes Care29, 356–362 (2006).

    PubMed  Google Scholar 

68. Ward, W. K. et al. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus.Diabetes34, 861–869 (1985).

    CAS PubMed  Google Scholar 

69. Ehrmann, D. A. et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.J. Clin. Invest.96, 520–527 (1995).

    CAS PubMed PubMed Central  Google Scholar 

70. Kahn, S. E. et al. Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging.J. Clin. Endocrinol. Metab.74, 1336–1342 (1992).

    CAS PubMed  Google Scholar 

71. Cavaghan, M. K., Ehrmann, D. A., Byrne, M. M. & Polonsky, K. S. Treatment with the oral antidiabetic agent troglitazone improves β cell responses to glucose in subjects with impaired glucose tolerance.J. Clin. Invest.100, 530–537 (1997).

    CAS PubMed PubMed Central  Google Scholar 

72. Jensen, C. C. et al. β-cell function is the major determinant of oral glucose tolerance in four ethnic groups in the United States.Diabetes51, 2170–2178 (2002).

    CAS PubMed  Google Scholar 

73. Knowles, N. G., Landchild, M. A., Fujimoto, W. Y. & Kahn, S. E. Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.Diabetes Care25, 292–297 (2002).

    CAS PubMed  Google Scholar 

74. Weyer, C., Bogardus, C., Mott, D. M. & Pratley, R. E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.J. Clin. Invest.104, 787–794 (1999).

    CAS PubMed PubMed Central  Google Scholar 

75. Festa, A., Williams, K., D'Agostino, R., Wagenknecht, L. E. & Haffner, S. M. The natural course of β-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.Diabetes55, 1114–1120 (2006).

    CAS PubMed  Google Scholar 

76. O'Rahilly, S. & Farooqi, I. S. Genetics of obesity.Phil. Trans. R. Soc. B361, 1095–1105 (2006).

    CAS PubMed PubMed Central  Google Scholar 

77. Barroso, I. Genetics of type 2 diabetes.Diabet. Med.22, 517–535 (2005).

    CAS PubMed  Google Scholar 

78. Andrulionyte, L., Zacharova, J., Chiasson, J. L. & Laakso, M. Common polymorphisms of thePPAR-γ2 (Pro12Ala) andPGC-1a (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.Diabetologia47, 2176–2184 (2004).

    CAS PubMed  Google Scholar 

79. Kaiyala, K. J. et al. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding.Am. J. Physiol.277, E659–E667 (1999).

    CAS PubMed  Google Scholar 

80. Hales, C. N. & Barker, D. J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.Diabetologia35, 595–601 (1992).

    CAS PubMed  Google Scholar 

81. Leung, N. et al. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men.Diabetologia247, 204–213 (2004).

    Google Scholar 

82. Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake.Nature404, 661–671 (2000).

    CAS PubMed  Google Scholar 

83. Otani, K. et al. Reduced β-cell mass and altered glucose sensing impair insulin-secretory function in βIRKO mice.Am. J. Physiol. Endocrinol. Metab.286, E41–E49 (2004).

    MathSciNet CAS PubMed  Google Scholar 

Download references